Vimarsana.com

Latest Breaking News On - Biocryst pharmaceuticals stock performance - Page 2 : vimarsana.com

BioCryst Pharmaceuticals (NASDAQ:BCRX) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS

BioCryst Pharmaceuticals (NASDAQ:BCRX) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Biocryst-pharmaceuticals
Biocryst-pharmaceuticals-inc
Needham-company
Biocryst-pharmaceuticals-stock-performance
Earnings-history-for-biocryst-pharmaceuticals
Biocryst-pharmaceuticals-company-profile
News-ratings-for-biocryst-pharmaceuticals-daily
Get-free-report
Cryst-pharmaceuticals
Biocryst-pharmaceuticals-daily

MA Private Wealth Acquires Shares of 12,700 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

MA Private Wealth Acquires Shares of 12,700 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Needham-company
Biocryst-pharmaceuticals
Biocryst-pharmaceuticals-stock-performance
Vanguard-group-inc
Quarter-for-biocryst-pharmaceuticals
Deerfield-management-companylp-series
Exchange-commission
Nasdaq
News-ratings-for-biocryst-pharmaceuticals-daily
Biocryst-pharmaceuticals-inc
Jump-financial

MA Private Wealth Acquires Shares of 12,700 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

MA Private Wealth acquired a new stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 12,700 shares of the biotechnology company’s stock, valued at approximately $76,000. A number of other hedge funds have also recently bought and sold shares […]

Quarter-for-biocryst-pharmaceuticals
Advisory-services-network
Nasdaq
Fairfield-bush
Third-bancorp
Lazard-asset-management
Biocryst-pharmaceuticals-company-profile
Biocryst-pharmaceuticals-inc
News-ratings-for-biocryst-pharmaceuticals-daily
Biocryst-pharmaceuticals
Needham-company

HC Wainwright Comments on BioCryst Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:BCRX)

HC Wainwright Comments on BioCryst Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:BCRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Biocryst-pharmaceuticals-company-profile
Fairfield-bush
Needham-company
Nasdaq
Jpmorgan-chase-co
Biocryst-pharmaceuticals-inc
China-universal-asset-management-co
Biocryst-pharmaceuticals-stock-performance
Fifth-third-bancorp
Third-bancorp

vimarsana © 2020. All Rights Reserved.